| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |